Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions

BACKGROUND: The Institute for Clinical and Economic Review (ICER) has emerged in a visible role in US health care. However, it is unclear to what extent US commercial health plans use ICER value assessments in their specialty drug coverage decisions. OBJECTIVE: To evaluate the relationship between I...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, James D, Enright, Daniel E, Panzer, Ari D, Cohen, Josh T, Ollendorf, Daniel A, Neumann, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387943/
https://www.ncbi.nlm.nih.gov/pubmed/36840954
http://dx.doi.org/10.18553/jmcp.2023.29.3.257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387943/
https://www.ncbi.nlm.nih.gov/pubmed/36840954
http://dx.doi.org/10.18553/jmcp.2023.29.3.257

Ejemplares similares